It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Cases of H1N1 Flu Virus in Canada
As of June 3rd 2009, a total of 1,795 laboratory-confirmed cases of H1N1 flu virus have been reported in 9 provinces and 3 territories in Canada
THE NORTHERN Territory's Health Minister was last night in self-imposed quarantine, with suspected swine flu.
The Northern Territory News reports Kon Vatskalis has met many leading members of the community since returning from Melbourne on Saturday, including Chief Minister Paul Henderson, six other Cabinet Ministers, rebel backbencher Marion Scrymgour, and CLP leader Terry Mills.
He has also dined with world leaders of the oil and gas industry, and met the Chinese Ambassador to Australia.
If Mr Vatskalis is found to have swine flu when his test results come back today, his contacts will be urged by health authorities to stay at home for a week.
Mr Vatskalis last night said he had a runny nose, fever and aches.
The U.S. government on Monday awarded a major flu vaccine contract to MedImmune, a Gaithersburg, Maryland-based pharmaceutical company.
The Department of Health and Human Services placed an initial 90-million-dollar order for the vaccine, intending to use it on high-risk populations in the event of a flu pandemic later in the year.
The contract comes less than two weeks after the department officials said they were setting aside about 1 billion dollars to test and purchase vaccines for the national stockpile to fight the unusual virus strain, called A/H1N1.
Under the deal, MedImmune will continue to make its seasonal flu vaccine, but will now also develop a vaccine targeted specifically at the A/H1N1 virus that has caused the World Health Organization (WHO) to raise the pandemic alert level to the fifth of six stages.
...Experts fear the virus, which has caused mostly mild flu cases so far, could become something more dangerous.
MedImmune's vaccine differs from traditional flu vaccines. It is a nasal spray instead of an injection. Another difference is that the vaccine is formulated using live -- but weakened – virus strains.
Experts believe that those differences present some potential advantages, including a more robust immune response since the vaccine is live and the ability to cross protect against other flu strains that may have drifted from the initial target.
CDC will host a telephone-only briefing to discuss an update in the investigation of cases of H1N1 Flu.
Listen only: 800-593-8926
PASSCODE: CDC Media
Important Instructions: If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.
This press briefing media will also be available via listen-only audio web site at www.videonewswire.com... We strongly encourage non-media participants to use the webcast.